Low-Dose Ketamine Infusion for Children With Sickle Cell Disease-Related Pain
NCT00595530
·
clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
3
Enrollment
OTHER
Sponsor class
Stopped
Lack of enrollment and patient interest in study
Conditions
Sickle Cell Disease
Interventions
DRUG:
ketamine
Sponsor
Connecticut Children's Medical Center